Growth factors (GFs), chemokines, cytokines, and other signaling molecules all play a role in wound healing and tissue regeneration. Numerous breakthroughs in the subject have shed light on the mechanics of wound healing, and different technical solutions have been proposed as a result of these scientific advances. However, the mechanisms of tissue regeneration following wound injury have yet to be fully understood. Current advancements in unique drug delivery systems (DDSs) that release growth factors (GFs) offer a huge opportunity to develop new medicines or improve the efficacy of existing treatments. These breakthroughs are especially important in the field of regenerative medicine, which is tackling challenges like wound healing and skin restoration. To this purpose, biocompatible biomaterials have been intensively investigated in order to improve DDS in vivo integration, increase the bioactivity of released medications, and deliver bioactive compounds in a targeted and regulated manner.
Important Alert:
X
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Cell and gene therapies in models of vascular brain disorders
Berislav V Zlokovic, University of Southern California, United States
Title : Artificial Intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix HT, United States
Title : 3D Bio printed cardiovascular tissue model for space based applications
Kunal Mitra, Florida Tech, United States
Title : Challenges in skeletal tissue engineering
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Human-like cancer tissue models as a drug screening platform
Karolina Valente, VoxCell BioInnovation, Canada